Covid-19: Favipiravir triggers a price war; new brand launched at Rs 39

According to industry insiders, many more brands are lined up for launch, including one from Cipla

Favipiravir, used to treat Covid-19 patients with mild to moderate symptoms, is witnessing a pricing war with more brands launching the oral antiviral tablet in the market

After Mumbai's Glenmark Pharma launched the drug here for Rs 103 per tablet in June, it revised the price recently to Rs 79 a tablet. Pune's Brinton Pharma got a nod for the tablets this week and they have chosen to price it for Rs 59 per tablet. Now another Mumbai based company Jenburkt Pharma has launched it for Rs 39 per tablet.

According to industry insiders, many more brands are lined up for launch,